Comorbidities in rheumatoid arthritis: the RBSMR studyHaddani Fz, Niamane R Hassikou H, Abdelhafid Guich et al.|International Journal of Clinical Rheumatology|2020Cited by 11
One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registryS. Fellous, F. Allali, Hanan Rkain et al.|Rheumatology International|2021Cited by 10
Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registryLamia Oulkadi, R. Bahiri, S. Rostom et al.|Rheumatology International|2021Cited by 9
Extra-Articular Manifestations in Patients with Ankylosing Spondylitis: Baseline Characteristics from the RBSMR StudyN. El Ouardi, L. Achemlal, Ihsane Hmamouchi et al.|Mediterranean Journal of Rheumatology|2022Cited by 8
Radiographic axial versus nonradiographic axial spondyloarthritis: Comparison of the disease activity parameters and the disease activity and functional scores: RBSMR studyS Bencherifa, Niamane R Bahiri R, Bouchra Amine et al.|International Journal of Clinical Rheumatology|2019Cited by 7